本文選題：子午流注　切入點(diǎn)：大黃穴位貼敷　出處：《山東大學(xué)》2017年碩士論文

【摘要】：研究目的探索"子午流注"理論指導(dǎo)下大黃穴位貼敷治療危重患者便秘的有效性及安全性,繼而為該治療方案在臨床治療工作中推廣使用提供理論依據(jù)。以期向危重患者提供更加優(yōu)質(zhì)的臨床醫(yī)療服務(wù),促使其病情得到控制,在較短時(shí)間內(nèi)改善便秘癥狀。研究方法選取2015年3月至2016年3月入住萊蕪市中醫(yī)院ICU的危重患者60例,利用隨機(jī)數(shù)字表法分為對(duì)照組和觀察組各30例。對(duì)照組采取口服莫沙必利治療,1片/次,3次/d。觀察組給予"子午流注"理論指導(dǎo)下大黃穴位貼敷治療,每日6:00,用生理鹽水清理穴位,將藥貼固定于神闕穴,每日1次,每次6 h。兩組患者均持續(xù)治療4個(gè)療程,7 d為一個(gè)療程。比較兩組患者臨床治療總有效率、不良反應(yīng)發(fā)生率、便秘癥狀積分、肛管運(yùn)動(dòng)功能、直腸肛管協(xié)調(diào)運(yùn)動(dòng)功能、直腸感覺功能等。結(jié)果1.觀察組治療總有效率93.3%,同期對(duì)照組治療總有效率80%。觀察組臨床療效優(yōu)于對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。2.治療后,觀察組排便間隔時(shí)間(0.64±0.15)分,排便速度(1.23±0.78)分,排便性狀(1.01 ±0.50)分,排便難度(0.92士0.35)分,便意(0-85±0.70)分。同期對(duì)照組排便間隔時(shí)間(1-15±0.13)分,排便速度(2.02±0.80)分,排便性狀(1.75±0.48)分,排便難度(1.53±0.34)分,便意(1.51±0.67)分。觀察組各指標(biāo)均明顯優(yōu)于對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。3.治療后,觀察組 RP(65.38±1.52)mmHg,HPZ(4.47±0.32)cm,MSP(194.37±1.50)mmHg,DSS(14.10±1.25)s。同期對(duì)照組RP(61.20±1.45)mmHg,HPZ(4.22±0.30)cm,MSP(185.69±1.41)mmHg,DSS(12.65±1.24)s。觀察組各指標(biāo)均明顯優(yōu)于對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。4.治療后,觀察組IRP(35.79±1.11)mmHg,RAP(46.90±1.41)mmHg,ARR(33.85±1.3)%,RAPG(-11.44±1.33)mmHg。同期對(duì)照組 IRP(33.08±1.20)mmHg,RAP(53.33± 1.45)mmHg,ARR(29.48± 1.35)%,RAPG(—15.24± 1.26)mmHg。觀察組各指標(biāo)均明顯優(yōu)于對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。5.治療后,觀察組直腸初始感覺閾值(25.10±0.85)ml,直腸初始排便感覺閾值(52.10±1.35)ml,直腸最大耐受量(141.73±4.25)ml。同期對(duì)照組直腸初始感覺閾值(22.37±0.90)ml,直腸初始排便感覺閾值(46.48±1.32)ml,直腸最大耐受量(134.99±4.11)ml。觀察組各指標(biāo)均明顯優(yōu)于對(duì)照組,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論1."子午流注"理論指導(dǎo)下大黃穴位貼敷治療危重患者便秘效果更佳、安全性更高,可滿足當(dāng)前患者臨床治療需求。2.在緩解便秘癥狀、改善肛管運(yùn)動(dòng)功能、直腸肛管協(xié)調(diào)運(yùn)動(dòng)功能、直腸感覺功能方面,"子午流注"理論指導(dǎo)下大黃穴位貼敷取得的效果更加明顯。3."子午流注"理論指導(dǎo)下大黃穴位貼敷治療可作為臨床治療危重患者便秘的優(yōu)選方案推廣使用。
[Abstract]:Objective to explore the efficacy and safety of rhubarb acupoint application in the treatment of severe constipation under the guidance of "Meridian flow" theory. Then it provides a theoretical basis for popularizing and using the treatment scheme in clinical treatment, in order to provide more high-quality clinical medical services to critically ill patients and to bring their condition under control. To improve constipation symptoms in a short period of time. Methods 60 critically ill patients admitted to ICU in Laiwu traditional Chinese Medicine Hospital from March 2015 to March 2016 were selected. The control group was divided into control group (n = 30) and observation group (n = 30). The control group was treated with oral mosapride for 3 times / d. The observation group was treated with "meridian flow" theory under the guidance of "rhubarb" acupoint application. At 6: 00 daily, the acupoints were cleaned with normal saline, and the drug was fixed at Shenque point once a day for 6 hours. The patients in both groups were treated continuously for 4 courses and 7 days as a course of treatment. The total effective rate of clinical treatment and the incidence of adverse reactions were compared between the two groups. Results 1. The total effective rate of treatment in the observation group was 93.3, and the total effective rate in the control group was 80 percent. The clinical efficacy of the observation group was better than that of the control group, and the clinical efficacy of the observation group was better than that of the control group. After treatment, the defecation interval time was 0.64 鹵0.15, the defecation rate was 1.23 鹵0.78, the defecation character was 1.01 鹵0.50, the defecation difficulty was 0.92 鹵0.35), the mean defecation time was 1-15 鹵0.13), the defecation velocity was 2.02 鹵0.80). The score of defecation character was 1.75 鹵0.48, the defecation difficulty was 1.53 鹵0.34, the defecation meaning was 1.51 鹵0.67). The indexes in the observation group were significantly better than those in the control group, and the difference was statistically significant (P0.05 .3.After the treatment, the RP(65.38 鹵1.52 mm HgPZ4.47 鹵0.32 cm ~ (-1) HgPZ) in the observation group was significantly higher than that in the control group (14.10 鹵1.25 / s). In the same period, the control group's RP(61.20 鹵1.45 mm HgHPZL 4.22 鹵0.30mm HHPZL was significantly superior to the control group (P < 0.01 鹵1.41 鹵1.41 mm HgDSS 12.65 鹵1.24s-1). After treatment, the IRP(35.79 of the observation group was 46.90 鹵1.41 鹵1.41 鹵1.41 鹵1.41 鹵1.31 鹵1.31 鹵3.85 鹵1.33 鹵1.33 鹵11.44 鹵1.33 鹵1.33 mm Hg / g respectively. After treatment, the IRP(33.08 鹵1.20 mm IRP(33.08 of the observation group was 29.48 鹵1.35 鹵1.35 鹵1.26 mm Hg.After the treatment, all the indexes in the observation group were significantly better than those in the control group (P 0.05. 5). In the observation group, the initial rectal sensory threshold was 25.10 鹵0.85ml, the rectal initial defecation threshold was 52.10 鹵1.35ml, the rectal maximum tolerance dose was 141.73 鹵4.25ml. In the control group, the rectal initial sensory threshold was 22.37 鹵0.90ml, the rectal initial defecation threshold was 46.48 鹵1.32ml, and the maximum rectal tolerance dose was 134.99 鹵4.11ml / ml. All of them were significantly superior to the control group. Conclusion 1. Under the guidance of "Meridian flow" theory, the application of rhubarb acupoint to treat severe constipation is more effective and safe, which can meet the current clinical treatment needs of patients with constipation. 2. In relieving constipation symptoms, Improve anal motor function, rectoanal coordination motor function, In rectal sensory function, under the guidance of "Meridian flow" theory, the effect of rhubarb acupoint application was more obvious. 3. Under the guidance of "Meridian flow" theory, rhubarb acupoint application therapy could be used as an excellent scheme for clinical treatment of constipation in critically ill patients.
【學(xué)位授予單位】：山東大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R248.9

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 孫義森,李梅;藥物穴位貼敷治療面癱97例[J];現(xiàn)代中西醫(yī)結(jié)合雜志;2000年20期

2 吳暉,莊金梅,李華,林禮興;穴位貼敷治療變應(yīng)性鼻炎239例[J];福建中醫(yī)學(xué)院學(xué)報(bào);2005年05期

3 胡雁;;穴位貼敷治療失眠的護(hù)理體會(huì)[J];臨床醫(yī)藥實(shí)踐雜志;2007年06期

4 王雨燕;王顯達(dá);;穴位貼敷治療膝關(guān)節(jié)骨性關(guān)節(jié)炎[J];中國(guó)民間療法;2008年09期

5 朱德志;巫云立;沈紅梅;許智;章彤;;穴位貼敷治療貼預(yù)防放療所致骨髓抑制[J];中國(guó)輻射衛(wèi)生;2009年04期

6 方紅;高艷麗;;隔藥灸臍法配合穴位貼敷治療慢性乙肝的療效觀察[J];光明中醫(yī);2012年06期

7 高秀成，王光彥，李守斌，，楊福建;定神癲癇袋穴位貼敷治療癲癇50例[J];中國(guó)針灸;1995年S1期

8 焦福全,周修子,閆清海;面癱膏穴位貼敷治療特發(fā)性面神經(jīng)麻痹590例臨床觀察[J];中國(guó)中西醫(yī)結(jié)合耳鼻咽喉科雜志;1999年02期

9 羅毅明;單味中草藥穴位貼敷治療痹證[J];湖北中醫(yī)雜志;2000年01期

10 吳堅(jiān)剛;指針配合穴位貼敷治療青少年近視120例[J];河南中醫(yī);2001年02期

相關(guān)會(huì)議論文 前10條

1 莊金梅;吳暉;李華;江里濤;鄭金秀;陳國(guó)春;鄭秀琴;林淑琴;林禮關(guān);;抗敏靈穴位貼敷治療變應(yīng)性鼻炎療效觀察(摘要)[A];第三屆第四次全國(guó)中西醫(yī)結(jié)合耳鼻咽喉科學(xué)術(shù)會(huì)論文匯編[C];2002年

2 蘇春倩;張桂蘭;;穴位貼敷治療頸椎病的護(hù)理及體會(huì)[A];中華醫(yī)學(xué)會(huì)急診醫(yī)學(xué)分會(huì)第十三次全國(guó)急診醫(yī)學(xué)學(xué)術(shù)年會(huì)大會(huì)論文集[C];2010年

3 張幼慈;于淑媛;聶紅霞;郭倩;;穴位貼敷治療變應(yīng)性鼻炎93例[A];第二十四屆航天醫(yī)學(xué)年會(huì)暨第七屆航天護(hù)理年會(huì)論文匯編[C];2008年

4 舒又媛;;溫針結(jié)合穴位貼敷治療膝關(guān)節(jié)骨性關(guān)節(jié)炎的療效觀察[A];第七屆中華中醫(yī)藥學(xué)會(huì)中醫(yī)外治學(xué)術(shù)年會(huì)論文匯編[C];2011年

5 鮑思安;;自制癤腫膏穴位貼敷治療外耳道癤腫[A];全國(guó)基層中醫(yī)臨床應(yīng)用學(xué)術(shù)會(huì)論文集[C];1996年

6 那林;李春林;;蒙藥穴位貼敷治療風(fēng)濕、類風(fēng)濕、神經(jīng)痛87例[A];全國(guó)民族醫(yī)藥專科專病學(xué)術(shù)研討會(huì)論文選編[C];2001年

7 李陽(yáng);許輝;;穴位貼敷治療哮喘120例臨床觀察[A];中國(guó)針灸學(xué)會(huì)臨床分會(huì)第三屆全國(guó)代表大會(huì)暨全國(guó)針灸臨床學(xué)術(shù)論壇論文集[C];2005年

8 吳暉;莊金梅;李華;江里濤;鄭金秀;陳國(guó)春;鄭秀琴;林淑琴;林禮興;;抗敏靈穴位貼敷治療變應(yīng)性鼻炎(摘要)[A];第三屆第二次全國(guó)中西醫(yī)結(jié)合耳鼻咽喉科學(xué)術(shù)大會(huì)論文匯編[C];2000年

9 魏秀玲;;穴位貼敷治療化療后便秘的護(hù)理[A];全國(guó)中醫(yī)、中西醫(yī)結(jié)合護(hù)理學(xué)術(shù)交流會(huì)議論文匯編[C];2011年

10 胡彩虹;;刮痧配合穴位貼敷治療過敏性鼻炎的療效觀察[A];2008全國(guó)砭石與刮痧療法學(xué)術(shù)交流大會(huì)論文匯編[C];2008年

相關(guān)重要報(bào)紙文章 前4條

1 記者 潘良蕾;看同一科 掛多次號(hào) 病人多跑路多花錢[N];聯(lián)合時(shí)報(bào);2010年

2 林中;穴位貼敷治療咳喘[N];民族醫(yī)藥報(bào);2006年

3 記者 周穎邋李學(xué)燕;搭建多學(xué)科綜合治療平臺(tái)[N];中國(guó)中醫(yī)藥報(bào);2007年

4 衣曉峰 楊曉春;中藥灌注栓塞加穴位貼敷治療肝癌[N];中國(guó)醫(yī)藥報(bào);2001年

相關(guān)博士學(xué)位論文 前1條

1 高敏;心絞痛貼膏穴位貼敷治療冠心病的基礎(chǔ)和臨床研究[D];遼寧中醫(yī)藥大學(xué);2013年

相關(guān)碩士學(xué)位論文 前10條

1 孔健;艾灸加穴位貼敷治療過敏性鼻炎的研究[D];山東中醫(yī)藥大學(xué);2014年

2 尹波;穴位貼敷治療慢性腎衰竭氮質(zhì)血癥期陽(yáng)虛質(zhì)的臨床研究[D];云南中醫(yī)學(xué)院;2016年

3 侯振善;穴位貼敷治療功能性消化不良的臨床研究[D];北京中醫(yī)藥大學(xué);2012年

4 陳燦;藿香正氣散穴位貼敷治療小兒腹瀉風(fēng)寒證的臨床觀察[D];湖南中醫(yī)藥大學(xué);2016年

5 劉瑋虹;穴位貼敷治療小兒反復(fù)下呼吸道感染（肺脾氣虛型）的回顧性研究[D];山東中醫(yī)藥大學(xué);2016年

6 羅先;“丁香止痛方”穴位貼敷治療癌性腹部脹痛的臨床研究[D];北京中醫(yī)藥大學(xué);2017年

7 于曉燕;“子午流注”指導(dǎo)下大黃穴位貼敷治療危重患者便秘的臨床研究[D];山東大學(xué);2017年

8 高永洋;穴位貼敷治療原發(fā)性三叉神經(jīng)痛的病例序列研究[D];北京中醫(yī)藥大學(xué);2013年

9 嚴(yán)秋林;內(nèi)服桂枝湯加味配合穴位貼敷治療常年性過敏性鼻炎[D];廣州中醫(yī)藥大學(xué);2011年

10 付德高;穴位貼敷治療功能性消化不良的臨床研究[D];湖北中醫(yī)藥大學(xué);2014年

本文編號(hào)：1666213